MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016

MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016

DALLAS, February 1, 2012 /PRNewswire via COMTEX/ -- The report "Biomarkers Market (Discovery Technologies, Applications & Indications) - Global Trends, Opportunities & Forecasts (2011 - 2020)", as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Browse market data tables and in-depth TOC on the "Biomarkers Market (Discovery Technologies, Applications & Indications) -Global Trends, Opportunities & Forecasts (2011 -2020)" http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html Early buyers will receive 10% customization on reports.

Biomarkers are defined by Biomarkers Consortium as "Characteristics that are objectively measured and evaluated as indicators of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic intervention." Biomarkers are an active area of medical research and are showing a growth due to the potential they hold for targeted therapy or personalized medicine.

Biomarker caters the need of biopharmaceutical companies in drug discovery and development process and companion diagnostics. The global Biomarker market is estimated to grow at a CAGR of 14.40% during the study period (2011-2016).

In this report, the global biomarker market is studied by the biomarker discovery technologies, its application in drug discovery & development process, personalized medicine and molecular diagnostics across major indications such as oncology, cardiology, neurology and other indications which include arthritis, renal failure, HIV, tuberculosis, and diabetes. North America is leading the global CTMS market with around 50% share in 2011.

The North American market as a whole are a growing demand for higher capacities of the disease, diagnosis and treatment of aging, a higher rate of technology adoption and requirements of a growing biomarkers market [ http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html ] in drug discovery and development. The U.S. is the largest market, and shows a remarkable growth opportunity. Europe is the second largest market while Asia-Pacific is the fastest growing region.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology [ http://www.marketsandmarkets.com/biotech-market-research-5.html ], chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com .

Contact: Mr. Rohan 7557 Rambler Road, Suite 727, Dallas, TX 75231 Tel: +1-888-6006-441 Email: [email protected] MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/ http://twitter.com/marketsmarkets

SOURCE MarketsandMarkets

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.